ATE273517T1 - Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins - Google Patents

Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins

Info

Publication number
ATE273517T1
ATE273517T1 AT97927555T AT97927555T ATE273517T1 AT E273517 T1 ATE273517 T1 AT E273517T1 AT 97927555 T AT97927555 T AT 97927555T AT 97927555 T AT97927555 T AT 97927555T AT E273517 T1 ATE273517 T1 AT E273517T1
Authority
AT
Austria
Prior art keywords
iso
ecp
cationic protein
cytotoxic
diagnostic method
Prior art date
Application number
AT97927555T
Other languages
English (en)
Inventor
Per Venge
Christer Peterson
Original Assignee
Pharmacia Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Diagnostics Ab filed Critical Pharmacia Diagnostics Ab
Application granted granted Critical
Publication of ATE273517T1 publication Critical patent/ATE273517T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT97927555T 1996-06-06 1997-06-06 Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins ATE273517T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602234A SE9602234D0 (sv) 1996-06-06 1996-06-06 A novel diagnostic method utilizing ECP, and reagents to be used in the methods
PCT/SE1997/000995 WO1997046885A1 (en) 1996-06-06 1997-06-06 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs)

Publications (1)

Publication Number Publication Date
ATE273517T1 true ATE273517T1 (de) 2004-08-15

Family

ID=20402902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927555T ATE273517T1 (de) 1996-06-06 1997-06-06 Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins

Country Status (8)

Country Link
US (1) US6733980B1 (de)
EP (1) EP0927354B1 (de)
JP (1) JP3876300B2 (de)
AT (1) ATE273517T1 (de)
DE (1) DE69730223T2 (de)
ES (1) ES2235235T3 (de)
SE (1) SE9602234D0 (de)
WO (1) WO1997046885A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130028A1 (de) * 2000-02-18 2001-09-05 Francesco Marcucci Verfahren zur Herstellung einer Schleimhautform des eosinophilen kationischen Proteins (ECP), Schleimhaut-ECP und seine Verwendung als allergischer Phlogosismarker
EP1549676A1 (de) * 2002-09-30 2005-07-06 Oncotherapy Science, Inc. Gene und polypeptide mit bezug zu menschlicher myeloider leukämie
WO2008144850A1 (en) * 2007-05-30 2008-12-04 Advanced Diagnostic Systems Ltd Assay for determining risk of development of allergic disorders
HK1220759A1 (zh) 2013-03-15 2017-05-12 Hycor Biomedical Llc 用於进行过敏症和自身免疫性疾病的诊断测定的自动化免疫分析系统
WO2020190682A1 (en) * 2019-03-15 2020-09-24 Research Institute At Nationwide Children's Hospital Compositions and methods for diagnosing acute infectious peritonitis
CN110361546A (zh) * 2019-08-28 2019-10-22 重庆三峡医药高等专科学校 一种检测嗜酸性粒细胞阳离子蛋白的胶体金试纸条

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085579A1 (en) * 1990-06-21 1991-12-22 Axis Biochemicals Asa Analyte variants analysis
US5567590A (en) * 1994-01-06 1996-10-22 National Jewish Center For Immunology And Respiratory Methods of diagnosing steroid-resistant inflammation due to type I or type II nuclear glucocorticoid receptor binding abnormalities

Also Published As

Publication number Publication date
ES2235235T3 (es) 2005-07-01
SE9602234D0 (sv) 1996-06-06
WO1997046885A1 (en) 1997-12-11
EP0927354B1 (de) 2004-08-11
US6733980B1 (en) 2004-05-11
EP0927354A1 (de) 1999-07-07
JP3876300B2 (ja) 2007-01-31
DE69730223T2 (de) 2005-09-15
DE69730223D1 (de) 2004-09-16
JP2000516702A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
US4609629A (en) Process for the immunological determination of proteins in body fluid which display a non-parallel inhibition curve to a reference inhibitor
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DK0930366T3 (da) Bindingsdomæner i Delta-proteiner
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
ATE474855T1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ATE51449T1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DE69821246D1 (de) Testverfahren für collagenpeptid
DE59008810D1 (de) Verfahren zum nachweis von malignen erkrankungen.
ATE138205T1 (de) Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
ATE273517T1 (de) Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
EP0725081A4 (de) MONOKLONALER ANTIKÖRPER GEGEN MxA DES MENSCHLICHEN Mx PROTEINS
Wang et al. Ab initio association with beta 2-microglobulin during biosynthesis of the H-2Ld class I major histocompatibility complex heavy chain promotes proper disulfide bond formation and stable peptide binding.
EP0245052A3 (de) Feststellung einer Entzündung und Antikörper dazu
ATE73463T1 (de) Monoklonale antikoerper.
DK1171157T3 (da) Anvendelse af glucose-6-phosphat-isomerase og antistoffer derimod til diagnosticering og behandling af arthritis, og test for anti-arthritis-forbindelser
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
WO2001015655A3 (en) Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders
WO1998047922A3 (en) Determination of recombinant glycosylated proteins and peptides in biological fluids
Lewis Screening for serum lipoprotein abnormalities: Comparison of ultracentrifugal, paper and thin‐layer starch‐gel electrophoresis techniques
KR890702037A (ko) 간장암 질환의 진단법
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
ZA955916B (en) Method for determining the lysine content of seeds
ATE271067T1 (de) An menschliches wachstumshormon (hgh) bindende monoklonale antikörper

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0927354

Country of ref document: EP

EEFA Change of the company name